Terrance McGuire, Director at ACCELERON PHARMA INC (XLRN), sold 407,259 shares at $30.25 ($12.3M) on 2015-08-17, disclosed to the SEC on 2015-08-26.
Open-market sale of $12.3M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |